EU Authorized Representative — Your Legal Gateway to the European Market
If your company is based outside the European Union and you want to sell medical devices in Europe, you are legally required to appoint an EU Authorized Representative under MDR Article 11. MEGACERT acts as your AR — registering your devices, managing regulatory communications, and ensuring you remain compliant year-round.
Who Needs an EU Authorized Representative?
Under EU MDR 2017/745 Article 11, any manufacturer established outside the European Union (including UK post-Brexit, Turkey, USA, Japan, China, and all other non-EU countries) must appoint an Authorized Representative (AR) before their medical device can bear the CE mark and be placed on the EU market.
The AR is not a distributor or agent — it is a legally designated entity with specific responsibilities defined in MDR Article 11(3):
- Registering the manufacturer and devices in EUDAMED
- Verifying that Declaration of Conformity and Technical Documentation are in place
- Forwarding complaints and Field Safety Corrective Actions to the manufacturer
- Cooperating with National Competent Authorities (NCAs) on request
- Being the regulatory point of contact for EU authorities
Critical: The AR's name and address must appear on the device label alongside the manufacturer's address.
MEGACERT Authorized Representative Services
EUDAMED Registration
We register your company as manufacturer and register each of your devices in EUDAMED (European Database on Medical Devices) — including UDI-DI/PI assignment, device classification, and NB reference data.
Declaration of Conformity (DoC) Co-Signing
As your AR, MEGACERT co-signs your Declaration of Conformity as required by MDR Annex IV, accepting shared regulatory responsibility.
Labelling Review
We review your device labelling to ensure the AR's address and the EU MDR symbol (EC REP) are correctly applied per MDR Annex I Chapter III.
Vigilance & Incident Management
We receive, log, and forward serious incident reports and FSCAs to you, and where required, report to NCAs within MDR timeframes (2 days for serious public health threats / 10 days for death or serious deterioration).
NCA Liaison
We act as the single point of contact for all National Competent Authority inquiries, market surveillance investigations, and inspection notifications across all 27 EU member states.
Annual Compliance Review
We conduct an annual review of your MDR compliance status — checking UDI system updates, EUDAMED record accuracy, PMSR/PSUR submission status, and Technical Documentation currency.
Our AR Service Tiers
| Service | Essentials | Professional | Enterprise |
|---|---|---|---|
| EUDAMED registration | ✓ | ✓ | ✓ |
| DoC co-signing | ✓ | ✓ | ✓ |
| Labelling review | — | ✓ | ✓ |
| Vigilance management | — | ✓ | ✓ |
| NCA liaison | — | ✓ | ✓ |
| Annual compliance review | — | — | ✓ |
| Number of devices | 1–3 | Up to 15 | Unlimited |
Contact us for pricing — all tiers available as annual contracts.
Frequently Asked Questions
Ready to enter the EU market with a trusted Authorized Representative? Contact MEGACERT today to discuss your AR needs.
Learn About Our AR Services →